Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Cyclin-Dependent Kinase Inhibitor 3 (CDKN3) Peptid

CDKN3 Reaktivität: Human Wirt: Synthetic BP, WB
Produktnummer ABIN974789
  • Target Alle CDKN3 Produkte
    CDKN3 (Cyclin-Dependent Kinase Inhibitor 3 (CDKN3))
    Spezies
    Human
    Quelle
    • 2
    Synthetic
    Applikation
    Blocking Peptide (BP), Western Blotting (WB)
    Produktmerkmale
    This is a synthetic peptide designed for use in combination with anti-CDKN3 antibody (Catalog #: ARP53629_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
    Aufreinigung
    Purified
  • Applikationshinweise
    Each Investigator should determine their own optimal working dilution for specific applications.
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Lyophilized
    Rekonstitution
    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
    Konzentration
    1 mg/mL
    Buffer
    Final peptide concentration is 1 mg/mL in PBS.
    Handhabung
    Avoid repeated freeze-thaw cycles.
    Lagerung
    -20 °C
    Informationen zur Lagerung
    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Target
    CDKN3 (Cyclin-Dependent Kinase Inhibitor 3 (CDKN3))
    Hintergrund
    CDKN3 belongs to the dual specificity protein phosphatase family. It was identified as a cyclin-dependent kinase inhibitor, and has been shown to interact with, and dephosphorylate CDK2 kinase, thus prevent the activation of CDK2 kinase. This gene was reported to be deleted, mutated, or overexpressed in several kinds of cancers. The protein encoded by this gene belongs to the dual specificity protein phosphatase family. It was identified as a cyclin-dependent kinase inhibitor, and has been shown to interact with, and dephosphorylate CDK2 kinase, thus prevent the activation of CDK2 kinase. This gene was reported to be deleted, mutated, or overexpressed in several kinds of cancers. Publication Note: This RefSeq record includes a subset of the publications that are available for this gene. Please see the Entrez Gene record to access additional publications.

    Alias Symbols: CDI1, CIP2, FLJ25787, KAP, KAP1, MGC70625

    Protein Interaction Partner: CDC25A,CDK1,CDK2,CDK3,CDKN3,CEBPA,MS4A3,CDK1,CDK2,MS4A3

    Protein Size: 212
    Molekulargewicht
    23 kDa
    Gen-ID
    1033
    NCBI Accession
    NM_005192, NP_005183
    UniProt
    Q16667
Sie sind hier:
Kundenservice